03-Nov-2026 18:14:50
AMRUTANJANGeneral news
AMRUTANJAN Q2 : STANDALONE NET PROFIT UP 23.8% AT ₹17.28 CR (YOY), UP 295.8% (QOQ). STRONG (ON 1ST LOOK)
• Revenue up 14.9% at ₹135.18 Cr (YOY), up 31.3% (QOQ). • Ebitda up 27.9% at ₹26.63 Cr (YOY), up 164.8% (QOQ); margins 19.7% v 17.7% (YOY), 9.8% (QOQ). • Caution: H1 PAT down 2.8% YOY at ₹21.65 Cr; Q1 FY27 had ₹2.03 Cr lease-rent exceptional item. • Board declared first interim dividend of Re 1/share for FY27, aggregating ₹2.89 Cr.
Amrutanjan Health Care Limited
Open attachment